Log in or Sign up for Free to view tailored content for your specialty!
Wound Management News
Catch up with top Healio Dermatology news from August
Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.
Ilya Pharma’s investigational treatment receives rare pediatric disease designation
The FDA has issued a rare pediatric disease designation to Ilya Pharma for its topical emilimogene sigulactibac treatment for STING-associated vasculopathy with onset in infancy, according to a press release.
Bromelain-based enzymatic debridement agent rapidly treats venous leg ulcer wounds
A new bromelain-based enzymatic debridement product was effective at rapidly debriding venous leg ulcer wounds without pain, according to this study.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves pediatric indication for NexoBrid for treatment of thermal burns
The FDA has approved a pediatric indication for NexoBrid for the treatment of deep partial-thickness and full-thickness thermal burns, Vericel Corporation announced in a press release.
Avita, Regenity enter development agreement for wound care product
Avita Medical Inc. has entered into an agreement with Regenity Biosciences to develop and distribute its collagen-based dermal matrix for wound healing, the company announced in a press release.
No infection increase seen after dermatologic surgery with early water exposure
Dermatologic surgery wounds that were exposed to water in the hours following surgery did not experience an increase in infection, hematoma or bruising, according to a study.
Top news of July: Permanent makeup, FDA approvals, tattoos, more
Healio has compiled July’s most-read news in dermatology.
Diagnostic delays, morbidity, mortality improving among patients with calciphylaxis
Time to diagnosis as well as morbidity outcomes and mortality rates among patients with calciphylaxis has steadily improved since 2006, according to a study.
Dupilumab should be considered as treatment option for bullous pemphigoid
Clinicians should consider dupilumab as a therapeutic option for bullous pemphigoid due to its ability to clear blistering and pruritus safely, according to a study.
Top news of June: Cancer risk, leaf extract, fungal infections, more
Healio has compiled June’s most-read news in dermatology.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read